T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 185 clinical trials
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

This is a phase II trial using a non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen with modifications based on factors including diagnosis, disease status, and prior treatment. Single or double unit selected according to current University of Minnesota umbilical cord blood graft selection algorithm.

oxygen saturation
chronic myeloid leukemia
consolidation chemotherapies
raeb i
acute leukemia
  • 42 views
  • 25 Jan, 2021
  • 1 location
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Chemokine receptor CXCR4 is normally expressed on T-lymphocytes, B-lymphocytes, monocytes, macrophages, neutrophils and eosinophils as well as hematopoietic stem and progenitor cells (HSPC) in the bone marrow. 68Ga-Pentixafor PET/CT represents a promising method for the in vivo assessment of the CXCR4 expression status in cancer patients, especially in hematologic malignancies. …

neutrophil count
cancer
hematologic malignancy
bone marrow procedure
  • 0 views
  • 11 Apr, 2021
  • 1 location
Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

This is a prospective phase II clinical trial to observe the efficacy and safety of Chidamide combined with VDDT(vinorelbineliposomal doxorubicindexamethasone and thalidomide) in relapsed and refractory patients with diffuse large B-cell lymphoma(DLBCL).

b-cell lymphoma
doxorubicin
neutrophil count
dexamethasone
  • 1 views
  • 24 Jan, 2021
  • 1 location
Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Study of Chidamide Combined With Immunotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Who Had Previously Received Platinum-based Chemotherapy

  • 0 views
  • 26 Jan, 2021
  • 1 location
Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas

The trial assess the maximum tolerated dose of a single-dose of Brentuximab Vedotin added to standard BeEAM chemotherapy (comprising Bendamustin, Etoposide, Cyclophosphamide and Melphalan) before autologous stem cell transplantation in CD30+ malignant lymphomas.

platelet count
t-cell lymphoma
etoposide
high dose chemotherapy
solid tumor
  • 4 views
  • 26 Jan, 2021
  • 1 location
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

ATG based conditioning regimen in HLA related allogeneic hematopoietic stem cell transplantation for aggressive T-cell tumors: multi-center, open, randomized controlled clinical study

  • 0 views
  • 21 Jan, 2021
  • 1 location
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

The purpose of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cell therapy against CD7-positive hematological malignancies using CD7 specific CAR T cells. The study also aims to learn more about the function of CD7 CAR T cells and their persistence in patients of …

flow cytometry
cancer
hematologic malignancy
ejection fraction
  • 4 views
  • 24 Jan, 2021
  • 1 location
A Single-arm Open Phase II Study of Chidamide Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma

Soft tissue sarcoma is a relatively rare malignant tumor with an incidence of about 1-2/100,000. The best way to obtain evidence-based medical evidence is to participate in clinical trials with new drugs (especially targeted drugs and immunotherapy). Chidamide, an oral subtype-selective histone deacetylase inhibitor monotherapy was effective on the patients …

ewing's sarcoma
malignant peripheral nerve sheath tumor
fibrosarcoma
angiosarcoma
liposarcoma
  • 2 views
  • 24 Mar, 2021
  • 1 location
Optimizing PTCy Dose and Timing

Background Stem cell or bone marrow transplants can cure or control blood cancers. Sometimes the donor cells see the recipient s body as foreign. This can cause complications. A high dose of the drug cyclophosphamide (PTCy) can help reduce these risks. Researchers want to see if a lower dose of …

chronic myeloid leukemia
leukemia
cyclosporine
cell transplantation
chronic myelomonocytic leukaemia
  • 42 views
  • 18 Mar, 2021
  • 1 location
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma

This randomized phase II trial studies how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back (recurrent) or does not respond to therapy (refractory). Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to …

platelet count
combination chemotherapy
carboplatin
HIV Infection
monoclonal antibody therapy
  • 17 views
  • 22 Mar, 2021
  • 7 locations